Bayer AG’s Werner Baumann, soon to take over as CEO, voiced his plans to bolster the company’s smallest unit -- animal health -- with acquisitions and partnerships, according to a Bloomberg article.
“We would really, really like to strengthen our animal health business,” Baumann told reporters at a briefing in Leverkusen, Germany. “The animal health business is a business that, for many years, we have been trying to start, to start strategically, which means inorganically, that is still our goal.”
Revenue at the unit, $1.71 billion last year, will probably grow only “slightly” this year, the article said.
Read the full story